20 domestic pharmaceutical bio companies announced their participation in the JPMorgan Healthcare Conference, which will be held early next year. Among them, Samsung Biologics was the only one to be assigned a main session presentation. Celltrion, who attended every time, declared absence after 10 years.

The JPMorgan Healthcare Conference, which marks its 39th year next year, is the largest conference in the bio field where global pharmaceutical companies share new drug R&D achievements and status, and understand trends in the global pharmaceutical industry. This conference will be held online from January 11th to 14th due to COVID-19.

◆Samsung Biologics debuts as new preside

Kim, Jin-Gu(kjg@dailypharm.com)